GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


Integrating Pharmacovigilance and consumption data analysis - uses, limitations and potentiality


Eu2P Short Course: Integrating Pharmacovigilance and consumption data analysis - uses, limitations and potentiality

OBJECTIVES

The technical evolution of databases as well as the new possibilities to analyze them has added new information sources to obtain valuable data describing the consumption of medicines at different levels.

The course intends to :

  • Highlight the importance of how patients actually use medicines in the appearance of adverse drug reactions.
  • Discuss some examples showing the potentiality of analysing the characteristics of use of medicines.
  • Help you to identify potential sources of information on medicines use.
  • Discuss strengths, limitations and biases of different sources of information describing medicines use.

plan, ADR, innapropriate, use, medecines

 

LEARNING OUTCOMES

At the end of the course, you will be able to :

  • Look at how patients are taking their medicines each time you assess any potential adverse drug reaction.
  • Identify when an inappropriate use of medicines can be the cause of an unnecessary adverse drug reaction.
  • Plan analyses of medicines utilization data sources in order to identify preventable adverse drug reactions.

 

120 minutes
Online based learning
English language
Certificate of Achievement
200 € / $230
REGISTER NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Prof. Albert Figueras

Consultant
World Health Organization


avatar

Roser Llop

Universitat Autònoma de Barcelona

avatar

Dr. Dolores Rodriguez

Universitat Autònoma de Barcelona


avatar

Nasop Experts Group

ISoP's North American chapter



COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 6 30 29 00 29

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners